Case number 1:18-cv-01699
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 14 | Motion to Dismiss for Failure to State a Claim (1) |
| Jul 9, 2020 | 1 | Complaint (16) |
| Mar 4, 2019 | 29 | Patent/Trademark Report to Commissioner (1) |
| Mar 4, 2019 | 29 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,459,938 B2; 9,566,289 B2; 9,566,290 B2; 9,572,823 B2. (Attachments: # (1) Notice of Voluntary Dismissal)(nms) |
| Mar 4, 2019 | 29 | Notice of Voluntary Dismissal (2) |
| Mar 4, 2019 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [28]. (nms) |
| Mar 1, 2019 | 28 | Notice of Voluntary Dismissal (2) Docket Text: NOTICE of Voluntary Dismissal by Anacor Pharmaceuticals, Inc. as to Mylan Pharmaceuticals Inc. and Mylan Inc. (Dellinger, Megan) |
| Mar 1, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Defendant FlatWing Pharmaceuticals, LLCs Motion to Stay Case Pending Resolution of Inter Partes Review (C.A. 18-1606, D.I. 23) is DENIED, and Plaintiffs Cross Motions to Stay All Cases Against All Defendants (C.A. 18-1606, D.I. 34; C.A. 18-1673, D.I. 46; C.A. 18-1699, D.I. 12) are DENIED. Ordered by Judge Richard G. Andrews on 3/1/2019. Associated Cases: 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:18-cv-01699-RGA(nms) |
| Feb 19, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [26] STIPULATION TO EXTEND to Respond to Motion to Dismiss to March 1, 2019 (*Reset Briefing Schedule: re [14] MOTION to Dismiss for. Answering Brief due 3/1/2019). Signed by Judge Richard G. Andrews on 2/19/2019. (nms) |
| Feb 15, 2019 | 26 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Plaintiff to Respond to Defendants' Motion to Dismiss for Improper Venue and for Failure to State a Claim to March 1, 2019 - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
| Feb 4, 2019 | N/A | SO ORDERED (0) |
| Feb 1, 2019 | 25 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Plaintiff to respond to Defendants Motion to Dismiss for Improper Venue and for Failure to State a Claim (D.I. 14) to February 15, 2019 - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
| Feb 1, 2019 | 24 | Reply Brief (18) Docket Text: REPLY BRIEF re [12] Cross-Motion to Stay All Cases Against All Defendants and Response to Defendant Flatwing's Motion to Stay Case filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
| Jan 18, 2019 | N/A | SO ORDERED (0) |
| Jan 18, 2019 | 23 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION and Proposed Order Extending Time - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 1/18/2019 (nms). |
| Jan 16, 2019 | N/A | SO ORDERED (0) |
| Jan 15, 2019 | 22 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 1/16/2019 (nms). |
| Jan 9, 2019 | 21 | Reply to Response to Motion (9) Docket Text: Response to [12] Cross-Motion to Stay All Cases Against All Defendants, filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) Modified on 1/10/2019 (nms). |
| Jan 4, 2019 | 20 | Redacted Document (7) |
| Jan 4, 2019 | 20 | Main Document (7) Docket Text: REDACTED VERSION of [16] Declaration of Keith Meckstroth, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Exhibits A-C)(Palapura, Bindu) Modified on 1/7/2019 (nms). |
| Jan 4, 2019 | 20 | Exhibit A-C (6) |
| Jan 4, 2019 | 19 | Redacted Document (20) Docket Text: REDACTED VERSION of [15] Opening Brief in Support, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) |
| Jan 4, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for the exhibits found at D.I. 16 has been replaced per counsel's request. Exhibit B has been corrected. (nms) |
| Jan 2, 2019 | N/A | SO ORDERED (0) |
| Dec 31, 2018 | 18 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION and Order - filed by Anacor Pharmaceuticals, Inc.. (Blumenfeld, Jack) Modified on 1/2/2019 (nms). |
| Dec 21, 2018 | 14 | Text of Proposed Order (1) |
| Dec 21, 2018 | 17 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan N.V. for Mylan Inc.; Corporate Parent Mylan Inc. for Mylan Pharmaceuticals Inc. filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) |
| Dec 21, 2018 | 14 | Main Document (1) Docket Text: MOTION to Dismiss for Improper Venue and Failure to State a Claim - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order)(Palapura, Bindu) Modified on 12/28/2018 (nms). |
| Dec 12, 2018 | N/A | SO ORDERED (0) |
| Dec 11, 2018 | 13 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Mylan to answer, move or otherwise respond to the Complaint to December 21, 2018 and for Mylan to respond to the Cross-Motion to Stay to January 9, 2019 - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) |
| Dec 10, 2018 | 12 | Motion to Stay (12) Docket Text: Cross-Motion to Stay All Cases Against All Defendants and Response to Defendant Flatwing's Motion to Stay Case - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 12/11/2018 (nms). |
| Dec 10, 2018 | N/A | Set Answering Brief Deadline (0) Docket Text: Set Answering Brief Deadline re [12] Cross-Motion to Stay All Cases Against All Defendants and Response to Defendant Flatwing's Motion to Stay Case. Answering Brief/Response due date per Local Rules is 12/24/2018. (nms) |
| Nov 19, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Wendy L. Devine for Mylan Inc.,Wendy L. Devine for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Nov 16, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:18-cv-01699-RGA (rjb) |
| Nov 15, 2018 | N/A | SO ORDERED (0) |
| Nov 13, 2018 | 11 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to December 11, 2018 - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) |
| Nov 12, 2018 | 10 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by David Ellis Moore on behalf of Mylan Inc., Mylan Pharmaceuticals Inc. (Moore, David) |
| Nov 9, 2018 | N/A | SO ORDERED (0) |
| Nov 7, 2018 | 9 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney T.O. Kong and Wendy Lynn Devine of Wilson Sonsini Goodrich & Rosati - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) |
| Nov 1, 2018 | 8 | Declaration (9) Docket Text: DECLARATION of Mailing to Mylan Inc., by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 11/28/2018 (nms). |
| Nov 1, 2018 | N/A | SO ORDERED (0) |
| Oct 31, 2018 | 7 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Aaron P. Maurer, David I. Berl, David M. Horniak and Anthony Sheh of Williams & Connolly LLP - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
| Oct 31, 2018 | 6 | Return of Service Executed (2) Docket Text: Return of Service Executed by Anacor Pharmaceuticals, Inc.. Mylan Pharmaceuticals Inc. served on 10/30/2018, answer due 11/20/2018. (Dellinger, Megan) |
| Oct 31, 2018 | N/A | Case Assigned/Reassigned (0) |
| Oct 30, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Mylan Inc. on 10/30/2018; Mylan Pharmaceuticals Inc. on 10/30/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (rwc) |
| Oct 29, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for Anacor Pharmaceuticals, Inc. filed by Anacor Pharmaceuticals, Inc. (rwc) |
| Oct 29, 2018 | 4 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/18/18. Date of Expiration of Patent: 2/16/26.Thirty Month Stay Deadline: 3/18/2021. (rwc) |
| Oct 29, 2018 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,459,938 B2 ;9,566,289 B2 ;9,566,290 B2 ;9,572,823 B2. (rwc) |
| Oct 29, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) |
| Oct 29, 2018 | 1 | Main Document (16) Docket Text: COMPLAINT - filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2492018.) - filed by Anacor Pharmaceuticals, Inc. (Attachments: # (1) Exhibit A - D, # (2) Civil Cover Sheet)(rwc) |
| Oct 29, 2018 | 1 | Civil Cover Sheet (1) |
| Oct 29, 2018 | 1 | Exhibit A - D (961) |
| Oct 29, 2018 | 1 | Complaint* (1) |
